16 employees
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA
2019
$7.7M
from 4 investors over 4 rounds
Tacalyx GmbH raised $7.7M on September 25, 2019
Investors: coparion, High-Tech Gründerfonds, Idinvest Partners and Creathor Ventures